Delivery Order SPE2DB24D2101-SPE2DB25FKJTA

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,062.34, is for the delivery of Multaq 400 mg tablets over a period ending on May 6, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Multaq 400 mg tablets. The contract has a ceiling value of $13,168.65 and an ultimate completion date of April 16, 2025. The contract is not set-aside and was awarded on April 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Multaq 400 mg tablets. The $18,267.20 firm fixed-price delivery order has an ultimate completion date of October 26, 2023 and was awarded on October 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Multaq 400 mg tablets. The contract has a ceiling value of $35,434.38 and a completion date of September 9, 2024. It is a firm fixed-price contract and is not set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,373.43, is for the delivery of Multaq 400 mg tablets. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,539.04, is for the delivery of Multaq 400 mg tablets over a period ending on May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Multaq 400 mg tablets. The award is for a Firm Fixed Price contract with a ceiling value of $14,819.35 and a completion date of September 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,161.50 contract provides the DLA with 4,563,399,610 units of the prescription drug Multaq 400 mg tablet. The order has an ultimate completion date of January 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,019.92 firm fixed-price delivery order is for the supply of 4568161278 Multaq 400 mg tablets. The contract has an ultimate completion date of May 7, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,044.70, is a delivery order for the medication Multaq 400 mg tablet 60s. It is a firm fixed-price contract with a completion date of May 5, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKJTA
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,109.86, is for the delivery of Multaq 400 mg tablets. It is not a set-aside contract, indicating open competition.

Amerisourcebergen Drug Corp is the prime contractor and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely a part of that larger contract vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/18/25, 9:54 AM